95711943c9df3f1ab5a93850a74a1766.jpg

AtlanticProCare Launches 3D Printing Program for Custom Prostheses Medical

by Medical

AtlanticProCare, New England’s leading provider of customized mobility solutions and custom prostheses for amputees, has partnered with several fabricators to test 3D printed prostheses. The Maine based prosthetics supplier is currently working with three 3D printing companies — Extremiti 3D, Create O&P and Standard Cyborg — each of whom have unique offerings based on proprietary software, hardware and materials. AtlanticProCare provides custom created CAD designs for the printers and then tests the outputs. AtlanticProCare is the only prosthetics and orthotics practice in Maine participating.

2aae1bcf65db721ee224535aa6a6680c.jpg

Concept Laser Makes a Case for Titanium (Vs PEEK) in 3D Printed Bone Implants Editorials

by Medical

The name Karl Leibinger Medizintechnik has been synonymous since 1979 with implants in craniomaxillofacial surgery. Karl Leibinger Medizintechnik is a company that belongs to the KLS Martin Group. Resorbable implants were added in 2000. The most recent development are patient-specific individual implants for correction through distraction and osteosynthesis in the event of traumas or deformities. Initially manufactured by conventional means, since 2013 these implants have also been manufactured additively. This is based on the LaserCUSING process from Concept Laser, whose M2 cusing machine is used at Karl Leibinger Medizintechnik. Behind this lies a simple basic approach which has the ability to transform surgery: for the individual patient rather than a standard solution. To manufacture patient-specific implants, Frank Reinauer, Head of Innovation and Production of Biomaterials at Karl Leibinger Medizintechnik, now consistently relies on additively manufactured implants.

f77aedb400a1473f9eabfeb24f2025f6.jpg

CELLINK System Used to 3D Bioprint Human Cartilage for Implantation in Mice Bioprinting

by Medical

Swedish researchers at Sahlgrenska Academy and Chalmers University of Technology have successfully induced human cartilage cells to live and grow in an animal model, using 3D bioprinting. The results will move development closer to a potential future in which it will be possible to help patients by giving them new body parts through 3D bioprinting. The results were recently presented in the journal Plastic and Reconstructive Surgery Global Open.

2fac0fd34e30201ea0d93f1065b1065f.jpg

EnvisionTEC Previews New Material for 3D Printing Indirect Bonding Trays at IDS 3D Printing Processes

by Medical

The new E-IDB material presented by EnvisionTEC at the IDS show, the largest dental show in the world, joins industry-leading dental library for production of dental and orthodontic models, castables, appliances and restorations. The company also announced expansion of the Vida 3D printer line for dental industry ewith high-speed cDLM model and a new partnership with 3Shape, whose 3Shape Trios scanner and Ortho Analyzer software work hand-in-hand with Vida for tray production.

2e9c759af1d11415ca1bf2a5abc7a087.jpg

European Patent Granted for OPM’s OsteoFab 3D Printed Implants 3D Printing Processes

by Medical

Oxford Performance Materials, Inc. (OPM), a leader in advanced materials science and high performance additive manufacturing (HPAM), today announced that it has received a Notice of Decision to Grant a Patent from the European Patent Office (EPO) for OPM’s invention on a “Customized Implant for Bone Replacement”, which leverages its OsteoFab implant manufacturing process, originally filed on December 5, 2011. The patent, which took effect on December 21, 2016, will be valid until August 7, 2029, and enables OPM to apply its high-performance additive manufacturing process to 3D print customized implants for bone replacement.

a9bd79ef9a69352aa7c54735e1afe2af.jpg

Stratasys Opens Enrollment for 3DHEART Clinical Study on Effects of 3D Printed Heart Models in Surgery 3D Printing Processes

by Medical

Stratasys, the 3D printing and additive manufacturing solutions market leader, today announced enrollment is now open for 3DHEART, an investigator initiated trial. 3DHEART, which stands for 3D Hearts Enabling A Randomized Trial, is a randomized, single-blind clinical trial to study the use of patient-specific 3D printed models in pre-operative planning for pediatric heart surgery. Stratasys is providing in-kind support with printing of the models to be used in the trial.